Healthy Extracts IncOTCQB:HYEX
- LAST PRICE2.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 2.0000
- Day Range---
- 52 Week Range
- Volume3
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Apr 1, 2024
Healthy Extracts Reports Record Fiscal Year 2023 Financial Results, from 5:41PM ET on Monday Apr 01, 2024 by Dow Jones
5:41PM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Healthy Extracts Inc | 5.9M | -2.3x | --- |
Scisparc Ltd | 3.3M | -1.1x | --- |
Americann Inc | 1.5M | -5.1x | --- |
Minerco Inc | 13.0K | 0.0x | --- |
RXElite Inc | 120.0 | 0.0x | --- |
Sentient Brands Holdings Inc | 6.4M | -14.0x | --- |
Company Information
Healthy Extracts, Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The Company operates through its two subsidiaries, BergaMet NA, LLC (Bergamet) and Ultimate Brain Nutrients, LLC (UBN). The Company develops, manufactures and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, Brain Activate-Gel and Brain Activate - ENERGY Gel.
Contact Information
- Headquarters
- 7375 COMMERCIAL WAY, SUITE 125HENDERSON, NV, United States 89011
- Phone
- 702-505-0471
- Fax
- ---
Executives
- President, Director
- Kevin Pitts
- Chief Financial Officer, Secretary
- Robert Madden
- Independent Director
- William Bossung
- Independent Director
- Bill Croyle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9M |
|---|---|
Revenue (TTM) | $2.5M |
Shares Outstanding | 3.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.69 |
EPS | $-0.86 |
Book Value | $0.32 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -90.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
